Mutation spectrum and prevalence of BRCA 1 and BRCA 2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia
โ Scribed by Riahi, A.; Kharrat, M.; Ghourabi, M. E.; Khomsi, F.; Gamoudi, A.; Lariani, I.; May, A. E.; Rahal, K.; Chaabouni-Bouhamed, H.
- Book ID
- 124169207
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 595 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0009-9163
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Among Asian countries, Pakistan has the highest rates of breast and ovarian cancer. To assess the contribution of the __BRCA1__ and __BRCA2__ germ line mutations to these high rates, we conducted the first study of 176 Pakistani breast and ovarian cancer patients, selected on family his
Here we report the study on BRCA1 and BRCA2 mutations in 12 Thai breast and/or ovarian cancer families and 6 early-onset breast or breast/ovarian cancer cases without a family history of cancer. Five distinct rare alterations were identified in each gene: four introducing premature stop codons, one
Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast and ovarian cancer. The complete coding sequence analysis of both genes was carried out in 197 breast/ovarian cancer patients from high-risk families and 53 patients with sporadic breast/ovarian cancer. In summary, 59 mu
The entire coding regions of BRCA1 and BRCA2 were screened for mutations by heteroduplex analysis in 51 Mexican breast cancer patients. One BRCA1 and one BRCA2 truncating mutation each was identified in the group of 32 (6%) early-onset breast cancer patients (< or =35 years). Besides these two likel